Guardian Pharmacy Services, Inc.’s (NYSE:GRDN) Quiet Period To End on November 5th

Guardian Pharmacy Services’ (NYSE:GRDN) quiet period is set to end on Tuesday, November 5th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on GRDN shares. Stephens started coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target for the company. Truist Financial started coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued a “buy” rating and a $22.00 price target for the company. Finally, Raymond James started coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target for the company.

Guardian Pharmacy Services Stock Performance

NYSE GRDN opened at $17.55 on Thursday. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $20.10.

Insider Activity

In other news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The shares were acquired at an average cost of $14.00 per share, with a total value of $499,996.00. Following the purchase, the director now directly owns 35,714 shares of the company’s stock, valued at approximately $499,996. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Stephens Inc. AR purchased a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $189,000. Allspring Global Investments Holdings LLC purchased a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $5,460,000. Finally, Seven Grand Managers LLC purchased a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $2,515,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.